
Whereas most pain due to cancer can be relieved with relatively simple methods using oral zzso as suggested by WHO guidelines, some patients may have difficult pain situations that require more complex zzso It is estimated that zzso % of cancer patients suffer from pain that is not easily zzso There are a number of factors that may reduce the efficacy of zzso in the management of cancer zzso zzso pain zzso and breakthrough pain zzso especially of the incident zzso have been identified as challenges for zzso In several zzso studies, these two mechanisms were associated with limited positive outcomes compared with other zzso zzso zzso has recently been described as representing a challenge for physicians in the clinical zzso The global response to zzso including the development of adverse effects, typically varies by individual and is likely genetically zzso Moreover, clinical evidence suggests that different zzso may produce different effect profiles, and so it is more appropriate to consider the response to each individual zzso rather than general zzso zzso This paper will review both pharmacological and procedural mechanisms and treatments of these difficult pain zzso 

